Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z5QM
|
||||
| Former ID |
DNC010419
|
||||
| Drug Name |
Benzaldehyde O-4-propoxyphenylcarbamoyl oxime
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula |
C17H18N2O3
|
||||
| Canonical SMILES |
CCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
||||
| InChI |
1S/C17H18N2O3/c1-2-12-21-16-10-8-15(9-11-16)19-17(20)22-18-13-14-6-4-3-5-7-14/h3-11,13H,2,12H2,1H3,(H,19,20)/b18-13+
|
||||
| InChIKey |
AIEVCSUZILYYSA-QGOAFFKASA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.